Modern cytoprotective drugs (antihypoxants, antioxidants): what is the phenomenon of popularity in cardiology and neurology?

The article describes the possibilities and perspectives of modern cytoprotectors, in particular Cytoflavin®, in the complex therapy of hypoxic brain states of various etiologies and the results of the study of its clinical effectiveness. Based on the literature data about the effectiveness of this drug in treatment of patients with acute and chronic cardiovascular diseases, it was concluded the feasibility of its use as an important component of pathogenetic therapy of these disorders.

Key words: cytoprotectors, cardiovascular disease, Cytoflavin®.

Published: 15.02.2017

References:

• Agafina A.A., Kovalenko A.A., Rumyantseva S.A. i dr. (2006) Effektivnost neyrometabolicheskogo protektora tsitoflavina u bolnyih, perenesshih ishemicheskiy insult, v rannem vosstanovitelnom periode (mnogotsentrovoe randomizirovannoe issledovanie). Vrach, 1: 60–65.
• Afanasev V.V. (2005) Tsitoflavin v intensivnoi terapii: posobie dlya vrachei. Taktik-Studio, Sankt-Peterburg, 28 s.
• Afanasev V.V., Lukyanova I.Yu. (2010) Osobennosti primeneniya tsitoflavina v sovremennoy klinicheskoy praktike. Taktik-Studio, Sankt-Peterburg, 80 s.
• Baraboy V.A. (2006) Bioantiokidantyi. Kniga plyus, Kiev, 461 s.
• Bulon V.V., Zarubina I.V., Kovalenko A.L. i dr. (2003) Tserebroprotektivnyii effekt Tsitoflavina pri zakryitoi cherepno-mozgovoi travme. Eksperiment. klin. farmakol., 6: 26–29.
• Burchinskiy S.G. (2004) Sovremennyie podhodyi k neyroprotektsii. Nov. med. farmats., 10–11: 6–7.
• Vereschagin N.V. (2004) Geterogennost insulta v klinicheskoi praktike. AtmosferA, Nervnyie bolezni, 1: 19–20.
• Vereschagin N.V., Tanashyan M.M., Fedorova T.N., Smirnova I.N. (2004) Antioksidantyi v angionevrologii. AtmosferA, Nervnyie bolezni, 3: 8–12.
• Vinichuk S.M., Prokopiv M.M., Cherenko T.M. (2010) Poisk novyih podhodov k lecheniyu ostrogo ishemicheskogo insulta. Ukr. nevrol. zhurn., 1: 8–19.
• Gnezditskiy V.V. (2000) Obratnaya zadacha EEG i klinicheskaya elektroentsefalografiya. Izd-vo Taganrog. gos. un-ta, 636 s.
• Dunaev V.V., Tishkin V.S., Evdokimov E.I. (1989) K mehanizmu deistviya riboksina. Farmakol. toksikol., 52: 56–58.
• Ivanova G.E., Suvorov A.Yu., Medvedeva N.M. i dr. (2012) Fraktsiya vyibrosa levogo zheludochka pri ehokardiograficheskom issledovanii u bolnyih s tserebralnyim insultom kak prediktor reabilitatsionnogo prognoza. Materialyi IV Mezhdunarodnogo kongressa «Neyroreabilitatsiya 2012», 49 s.
• Ivnitskii Yu.Yu., Golovko A.I., Sofronov G.A. (1998) Yantarnaya kislota v sisteme sredstv metabolicheskoi korrektsii funktsionalnogo sostoyaniya rezistentnosti organizma. Lan, Sankt-Peterburg, 82 s.
• Kovalenko A.L., Bizenkova M.N., Bulon V.V. i dr. (2006) Patogeneticheskoe obosnovanie i farmakoterapevticheskaya effektivnost primeneniya Tsitoflavina pri ostroy ishemii mozga. Vestn. Sankt-Peterburg. gos. med. akad. im. I.I. Mechnikova, 3: 79–83.
• Kolman Ya.R. (2000) Naglyadnaya biohimiya. Mir, Moskva, 469 s.
• Konstanadov E.A., Cheremushkin E.A. (2012) Dinamika indutsirovannoy korkovoy aktivnosti. Zhurn. vyissh. nerv. deyat., 62(3): 311–321.
• Lesiovskaya E.E. (2012) Antigipoksantyi pryamogo deystviya — perspektivnyie neyroprotektoryi. Terra Medica, 4: 49–57.
• Livanov G.A. (2009) Ispolzovanie metabolicheskogo antioksidanta Tsitoflavina v korrektsii gipoksii i ee posledstvii pri tyazhelyih formah otravlenii neirotropnyimi yadami. Vestn. intens. ter., 1: 60–63.
• Livanov G.A., Bototsyirenov B.V., Glushkov S.I. i dr. (2004) Primenenie tsitoflavina pri toksicheskoi i postgipoksicheskoi entsefalopatii (posobie dlya vrachei). Sankt-Peterburg, s. 4–34.
• Livanov G.A., Moroz V.V., Bototsyirenov B.V. i dr. (2003) Puti farmakologicheskoi korrektsii posledstvii gipoksii pri kriticheskih sostoyaniyah u bolnyih s ostryimi otravleniyami. Anesteziol. reanimatol., 2: 51–54.
• Lukyanova L.D. (2002) Sovremennyie predstavleniya o bioenergeticheskih mehanizmah adaptatsii k gipoksii. Hyp. Med. J., 10(3–4): 30–43.
• Lukyanova L.D., Lukyanova A.D. (2004) Rol bioenergeticheskih narusheniy v patogeneze gipoksii. Pat. fiziol. i eksp. ter., 2: 2–11.
• Markova I.V., Afanasev V.V., Tsyibulkin E.K. (1999) Klinicheskaya toksikologiya detei i podrostkov. Intermedika, Sankt-Peterburg, 1: 329.
• Moybenko A.A., Dosenko V.E., Parhomenko A.N. (red.) (2008) Endogennyie mehanizmyi kardioprotektsii kak osnova patogeneticheskoy terapii zabolevaniy serdtsa. Naukova dumka, Kiev, 511 s.
• Nadiradze Z.Z., Bahareva Yu.A., Karetnikov I.A. (2006) Tsitoflavin kak dopolnitelnyiy metod zaschityi miokarda pri operatsiyah s iskusstvennyim krovoobrascheniem. Obsch. reanimatol., 2(3) (http://www.reanimatology.com/rmt/article/view/1147).
• Nartsissov R.P., Petrichuk S.V., Duhova Z.N. (1997) Tsitohimicheskaya ekspertiza kachestva zhizni — vchera, segodnya, zavtra. Yantarnaya kislota v meditsine, pischevoi promyishlennosti, selskom hozyaistve. Puschino, s. 155–165.
• Odinak M.M., Skvortsova V.I., Voznyuk I.A. i dr. (2010) Otsenka effektivnosti tsitoflavina u bolnyih v ostrom periode ishemicheskogo insulta. Zhurn. nevrol. psihiatr. im. S.S. Kormakova, 110: 12–29.
• Pavlova T.K. (2006) Kompleksnaya profilaktika i lechenie poliorgannoi nedostatochnosti u patsientov s infektsionnyim endokarditom. Avtoref. … dis. kand. med. nauk. Nizhniy Novgorod, 21 s.
• Parfenov V.A. (2002) Metabolicheskaya terapiya ishemicheskogo insulta. RMZh (Russkiy meditsinskiy zhurnal), 10(25): 21–30.
• Rozenfeld A.D. (1983) Regulyatsiya suktsinatom vklada mitohondrii v podderzhanie rN pri ATFaznyih nagruzkah. Avtoref. … dis. kand. med. nauk, Moskva, 21 s.
• Rumyantseva S.A., Bolevich S.B.,Silina E.V., Fedin A.I. (2007) Antioksidantnaya terapiya gemorragicheskogo insulta. Meditsinskaya kniga, Moskva, 69 s.
• Rumyantseva S.A., Kuznetsov O.R., Evseev V.N. i dr. (2005) Energokorrektsiya Tsitoflavinom v ostryiy period insulta. Vestn. intens. ter., 3: 23–26.
• Rumyantseva S.A., Oganov R.G., Silina E.V., Stupin V.A. i dr. (2012) Sovremennyie kontseptsii lecheniya patsientov s sosudistoy komorbidnostyu. Ch. 1. Korrektsiya tkanevogo energodefitsita. Kardiovask. ter. profil., 11(6): 44–49.
• Rumyantseva S.A., Stupin V.A., Afanasev V.V. i dr. (2014) Ratsionalnaya farmakoterapiya pri sosudistoy patologii. Meditsinskaya kniga, Moskva, Sankt-Peterburg, 339 s.
• Saiko O.V., Stadnik S.M. (2010) Efektyvnist neirometabolichnoho protektora tsytoflavinu pry infarktakh mozku u vertebrobazyliarnomu baseini. Prakt. anhiol., 7: 52–55.
• Silina E.V., Rumyantseva S.A. (2006) Korrektsiya oksidantnogo stressa pri vnutrimozgovyih krovoizliyaniyah metabolicheskim tsereboprotektorom Tsitoflavinom. Vestn. intens. ter., 2: 82–88.
• Silina E.V., Rumyantseva S.A., Bolevich S.B., Menshova N.I. (2011) Zakonomernosti techeniya svobodnoradikalnyih protsessov i prognoz ishemicheskogo i gemorragicheskogo insulta. Zhurn. nevrol. psihiatr. im. S.S. Korsakova, 12(2): 36–42.
• Skvortsova V.I., Efremova N.V., Shamalov N.A. i dr. (2006) Tserebralnaya ishemiya i neiroprotektsiya. Kachestvo zhizni. Meditsina, 2(13): 35–42.
• Suslina Z.A. (2004) Ishemicheskii insult: printsipyi lecheniya v ostreishem periode. AtmosferA. Nervnyie bolezni, 1: 14–18.
• Fedin A.I., Rumyantseva S.A., Kuznetsov O.R. i dr. (2005a) Effektivnost neirometabolicheskogo protektora Tsitoflavina pri infarktah mozga. Vestn. Sankt-Peterburg. gos. med. akad. im. I.I. Mechnikova, 1: 13–19.
• Fedin A.I., Rumyantseva S.A., Kuznetsov O.R., Evseev V.N. (2004) Antioksidantnaya i energoprotektornaya terapiya ishemicheskogo insulta. Metod. posobie. Taktik-studio, Moskva, s. 4–17.
• Fedin A.I., Rumyantseva S.A., Piradov M.A. i dr. (2005b) Effektivnost neyrometabolicheskogo protektora tsitoflavina pri infarktah mozga (mnogotsentrovoe randomizirovannoe issledovanie). Novyie tehnologii, metodyi diagnostiki, lecheniya i profilaktiki, 1(6): 13–19.
• Fedin A.I., Rumyantseva S.A., Piradov M.A. i dr. (2006) Effektivnost neyrometabolicheskogo protektora Tsitoflavina pri infarktah mozga (mnogotsentrovoe randomizirovannoe issledovanie). Vrach, 13: 13–23.
• Fedin A.I., Rumyantseva S.A.,Kuznetsov O.R. i dr. (2004) Antioksidantnaya i energoprotektornaya terapiya ishemicheskogo insulta. Metod. posobie. Moskva, 48 s.
• Shevchenko L.A., Evdokimov V.A. (2007) K voprosu ob effektivnosti primeneniya sovremennogo polimodalnogo preparata Tsitoflavin u lits s progressiruyuschimi disgemicheskimi porazheniyami golovnogo mozga. Mezhdunar. nevrol. zhurn., 3(13) (http://www.mif-ua.com/archive/article/122).
• Arakawa S., Perera N., Donnan G.A. (2005) Neuroprotection in stroke. ACNR, 5(5): 10–11.
• Brinjikji W., Murad M.H., Rabinstein A.A. et al. (2015) Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis. AJNR Am. J. Neuroradiol., 36(3): 525–529.
• Di Paolo G., De Camilli P. (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature, 443(7112): 651–657.
• Ferrari R., Cargnoni A., Ceconi C. et al. (1987) Role of oxygen in myocardial ischaemic and reperfusion damage: protective effects of vitamin E. In.: Clinical and nutritional aspects of vitamin E. Elsevier, Amsterdam, р. 209–226.
• Jauch E.C., Saver J.L., Adams H.P.Jr. et al.; Council on Clinical Cardiology (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 44(3): 870–947.
• Kalkan S., Aygoren O., Akgun A. et al. (2004) Do adenosine receptors play a role in amitriptyline-induced cardiovascular toxicity in rats? J. Toxicol. Clin. Toxicol., 42(7): 945–954.
• Kendell E., Swartz J., Jessel T. (Eds.) (2000) Principles of Neural Sciences. Appleton and Lange, 1134 p.
• Kidwell C.S., Jahan R., Gornbein J. et al.; MR RESCUE Investigators (2013) A trial of imaging selection and endovascular treatment for ischemic stroke. N. Engl. J. Med., 368(10): 914–923.
• Oganov R.G. (2006) Cardiology. Medical Book, Moscow, 678 p.